News & Resources



Congress Video

Impact of age, Recurrence Score (RS) and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Analysis of ADAPT and ADAPTcycle trials

Published: 20 September 2022

Presentation from ESMO 2022, Paris

Licensed with permission from the European Society for Medical Oncology (ESMO). All rights reserved.
The mention of any company, product, service, or therapy in this collection of materials does not constitute an endorsement of any kind by ESMO.

Sign up for new content alerts

Enter your email address below and we'll contact you as soon as new content is launched!

HCP confirmation(Required)
Privacy Policy Acceptance(Required)
This field is for validation purposes and should be left unchanged.

Create your first navigation menu here

Login / register

"*" indicates required fields

Healthcare Professional

Can you spare 2 minutes to share some feedback?